Tiantan Biotech: Tiantan Biotech 2021 Annual Equity Distribution Implementation Notice
Tiantan Biotech: Announcement on the proposed purchase of the underlying assets approved to set up two single plasma collection stations
Tiantan Biotech: Report on the Implementation of Major Asset Sales and Purchases and Related Transactions
Tiantan Biotech: Report on Sale and Purchase of Major Assets and Related Transactions (Draft) (Revised Draft)
Tiantan Biotech: Major Asset Sale and Purchase and Related Transactions Report (Draft) Summary (Revised Draft)
Tiantan Biotech: Major Asset Sales and Purchase and Related Transactions Report (Draft)
Tiantan Biotech: The Board's explanation that the company's stock price fluctuations did not meet the relevant standards of the “Notice on Regulating the Disclosure of Information Disclosure of Listed Companies and the Conduct of Related Parties” before th
Tiantan Biotech: Major Asset Sales and Purchase and Related Transactions Report (Draft) Summary
Tiantan Biotech: Report on the Implementation of Major Asset Purchases and Issuance of Shares to Purchase Assets and Announcement of Stock Changes
Tiantan Biotech: Announcement on Major Asset Purchases and Issuance of Shares to Purchase Assets and Complete Transfer of Assets Subject to Related Transactions
Tiantan Biotech: Announcement on the progress of implementation of major asset restructuring
Tiantan Biotech: Announcement on the progress of implementation of major asset restructuring
Tiantan Biotech: Announcement on the progress of implementation of major asset restructuring
Tiantan Biotech: Announcement on the progress of implementation of major asset restructuring
Tiantan Biotech: Announcement on the progress of implementation of major asset restructuring
Tiantan Biotech: Announcement on the progress of implementation of major asset restructuring
Tiantan Biotech: Announcement on Abnormal Fluctuations in Stock Trading
Tiantan Biotech: Announcement on the progress of restructuring
Tiantan Biotech: Announcement on the progress of restructuring
Tiantan Biotech: Announcement on Abnormal Fluctuations in Stock Trading